Literature DB >> 10179704

The influence of ill-health experience on the valuation of health.

X Badia1, M Herdman, P Kind.   

Abstract

Social valuations for health states are potentially useful both in clinical decision-making and in health-resource allocation, but there is some evidence that the experience of illness may affect such valuations. This article compares valuations of hypothetical health states obtained from a sample of chronically ill patients, with valuations obtained from a sample of relatively healthy individuals. The instrument used to obtain these values was the EuroQOL 5D questionnaire (EQ-5D). We found that the EQ-5D values of chronically ill patients differed significantly from the values obtained from healthier individuals, particularly in the case of the more severe health states. Healthy individuals assigned negative values to some hypothetical health states, indicating that they consider them to be worse than death, whereas chronically ill patients assigned positive values to all health states. These results raise difficult questions about whose values should count when health-status measures are incorporated in clinical and economic evaluation, and in particular when deciding upon the allocation of scarce resources.

Entities:  

Mesh:

Year:  1998        PMID: 10179704     DOI: 10.2165/00019053-199813060-00005

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


  12 in total

1.  Eliciting EuroQol descriptive data and utility scale values from inpatients. A feasibility study.

Authors:  C Selai; R Rosser
Journal:  Pharmacoeconomics       Date:  1995-08       Impact factor: 4.981

Review 2.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

Review 3.  Methods for quality adjustment of life years.

Authors:  E Nord
Journal:  Soc Sci Med       Date:  1992-03       Impact factor: 4.634

4.  Inconsistency and health state valuations.

Authors:  P Dolan; P Kind
Journal:  Soc Sci Med       Date:  1996-02       Impact factor: 4.634

5.  The effect of past and present illness experience on the valuations of health states.

Authors:  P Kind; P Dolan
Journal:  Med Care       Date:  1995-04       Impact factor: 2.983

6.  Measuring preferences for health states worse than death.

Authors:  D L Patrick; H E Starks; K C Cain; R F Uhlmann; R A Pearlman
Journal:  Med Decis Making       Date:  1994 Jan-Mar       Impact factor: 2.583

7.  Measurement of quality of life in end-stage renal disease: the time trade-off approach.

Authors:  D N Churchill; G W Torrance; D W Taylor; C C Barnes; D Ludwin; A Shimizu; E K Smith
Journal:  Clin Invest Med       Date:  1987-01       Impact factor: 0.825

8.  The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups?

Authors:  J Ashby; M O'Hanlon; M J Buxton
Journal:  Qual Life Res       Date:  1994-08       Impact factor: 4.147

9.  Weights for scoring the quality of well-being instrument among rheumatoid arthritics. A comparison to general population weights.

Authors:  D J Balaban; P C Sagi; N I Goldfarb; S Nettler
Journal:  Med Care       Date:  1986-11       Impact factor: 2.983

10.  Measuring health status in the community: a comparison of methods.

Authors:  P Kind; C M Gudex
Journal:  J Epidemiol Community Health       Date:  1994-02       Impact factor: 3.710

View more
  12 in total

1.  Feasibility, validity and test-retest reliability of scaling methods for health states: the visual analogue scale and the time trade-off.

Authors:  X Badia; S Monserrat; M Roset; M Herdman
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

2.  Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

Authors:  Adam Lowy; Jürg Bernhard
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

Review 3.  Treatment preferences in human papillomavirus-associated oropharyngeal cancer.

Authors:  Melina J Windon; Gypsyamber D'Souza; Carole Fakhry
Journal:  Future Oncol       Date:  2018-09-28       Impact factor: 3.404

4.  Normative values of EQ-5D-5L: in a Spanish representative population sample from Spanish Health Survey, 2011.

Authors:  M A Garcia-Gordillo; J C Adsuar; P R Olivares
Journal:  Qual Life Res       Date:  2015-10-19       Impact factor: 4.147

5.  Does diabetes have an impact on health-state utility? a study of Asians in Singapore.

Authors:  P Wang; E S Tai; J Thumboo; Hubertus J M Vrijhoef; Nan Luo
Journal:  Patient       Date:  2014       Impact factor: 3.883

Review 6.  Economic and health-related quality of life considerations of new therapies in Parkinson's disease.

Authors:  L M Rubenstein; A DeLeo; E A Chrischilles
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

7.  Race and gender associations between obesity and nine health-related quality-of-life measures.

Authors:  Tanya G K Bentley; Mari Palta; Adam J Paulsen; Dasha Cherepanov; Nancy Cross Dunham; David Feeny; Robert M Kaplan; Dennis G Fryback
Journal:  Qual Life Res       Date:  2011-03-10       Impact factor: 4.147

8.  Are patients' judgments of health status really different from the general population?

Authors:  Paul Fm Krabbe; Noor Tromp; Theo Jm Ruers; Piet Lcm van Riel
Journal:  Health Qual Life Outcomes       Date:  2011-05-11       Impact factor: 3.186

9.  Parents' reported preference scores for childhood atopic dermatitis disease states.

Authors:  Joëlle Y Friedman; Shelby D Reed; Kevin P Weinfurt; Kristijan H Kahler; Emmanuel B Walter; Kevin A Schulman
Journal:  BMC Pediatr       Date:  2004-10-18       Impact factor: 2.125

10.  Health-related quality of life variations by sociodemographic factors and chronic conditions in three metropolitan cities of South Asia: the CARRS study.

Authors:  Kavita Singh; Dimple Kondal; Roopa Shivashankar; Mohammed K Ali; Rajendra Pradeepa; Vamadevan S Ajay; Viswanathan Mohan; Muhammad M Kadir; Mark Daniel Sullivan; Nikhil Tandon; K M Venkat Narayan; Dorairaj Prabhakaran
Journal:  BMJ Open       Date:  2017-10-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.